资讯

Exclusive: US pharma tariffs would raise US drug costs by $51 billion annually, report finds
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
Trump’s planned pharmaceutical tariffs would raise costs by $51bn annually, report finds
Prices of medication and other costs could increase by as much as 12.9 percent if the tariffs are put in place ...
Pharma tariffs could raise prescription drug costs by $51B - report
A report from industry trade group Pharmaceutical Research and Manufacturers of America (PhRMA), conducted by Ernst & Young, ...
Pharmaceutical tariffs: Which countries does the U.S. import the most from?
The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...
MyChesCo on MSN16 小时
ProRx Pharma Expands Preventive Care Line with Six New Injectable Products
ProRx Pharma has announced the addition of six injectable products to its portfolio, aimed at supporting the growing demand ...
Trump’s pharmaceutical tariffs will risk the lives of American patients
In addition to pharmaceuticals, Trump has also called for Section 232 investigations of semiconductors and critical minerals.
PharmiWeb1 天
Pharmaceutical Manufacturing Equipment Market Growth Forecast CAGR 6-8% Key Trends ...
The pharmaceutical manufacturing equipment market is projected to grow at a CAGR of 6-8% during the forecast period. Growth ...
US business lobby in China: Some pharma firms reporting tariff exemptions
Pharmaceutical companies in China are reporting that they have been able to import some drugs over the past week with tariff ...
The Business Times9 小时
US pharma tariffs would raise US drug costs by US$51 billion annually, report finds
LONDON] A 25 per cent US tariff on pharmaceutical imports would increase US drug costs by nearly US$51 billion annually, ...
Union Leader10 小时
Pharma tariffs would raise U.S. drug costs by $51 billion annually, report finds
A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S.